US 8110209
Intracutaneous injection
granted A61KA61K38/26A61K38/27
Quick answer
US patent 8110209 (Intracutaneous injection) held by XERIS PHARMACEUTICALS, INC. expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XERIS PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/26, A61K38/27, A61K47/14, A61K47/22